Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.460
-0.040 (-1.60%)
Nov 21, 2024, 2:09 PM EST - Market open
Nkarta Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
150
Market Cap
173.60M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNKTX News
- 9 days ago - Nkarta to Participate in an Upcoming Investor Conference - GlobeNewsWire
- 13 days ago - Nkarta Reports Third Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 6 weeks ago - Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month - Benzinga
- 2 months ago - Nkarta to Participate in Upcoming Investor Conference - GlobeNewsWire
- 3 months ago - Nkarta: NK Cell Therapy Biotech With Good Standing Targeting R/R NHL Patients - Seeking Alpha
- 3 months ago - Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 3 months ago - Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus - GlobeNewsWire